Surgeons play a central role in the utilization of adjuvant chemotherapy for colorectal cancer

Diseases of the Colon and Rectum

Volumn 56, Issue 12, 2013, Pages 1327-1329

  Mutch, Matthew ^a  

^a Campus Box 8109 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LEVAMISOLE; OXALIPLATIN;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; COMORBIDITY; DISEASE FREE SURVIVAL; EDITORIAL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; LAPAROSCOPIC SURGERY; MEDICAL ONCOLOGIST; OVERALL SURVIVAL; RISK REDUCTION; SURGEON; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RECTAL NEOPLASMS; TIME-TO-TREATMENT;

EID: 84888342693     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e3182a854cb     Document Type: Editorial

References (16)

1. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322: 352-358.
2. André T, Boni C, Mounedji-Boudiaf L, et al; Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350: 2343-2351.
3. Lima IS, Yasui Y, Scarfe A, Winget M. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage II colon cancer in Alberta, Canada. Cancer. 2011;117: 3833-3840.
4. Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109: 975-982.
5. Hu CY, Delclos GL, Chan W, Du XL. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-II colon cancer. Med Oncol. 2011;28: 1062-1074.
6. Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS. Referral to medical oncology: a crucial step in the treatment of older patients with stage II colon cancer. Oncologist. 2006;11: 1025-1033.
7. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345: 1091-1097.
8. Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002;136: 349-357.
9. Kim KY, Cha IH, Ahn JB, et al. Estimating the adjuvant chemotherapy effect in elderly stage II and II colon cancer patients in an observational study. J Surg Oncol. 2013;107: 613-618.
10. Abraham A, Habermann EB, Rothenberger DA, et al. Adjuvant chemotherapy for stage II colon cancer in the oldest old: results beyond clinical guidelines. Cancer. 2013;119: 395-403.
11. White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer. 2010;116: 4622-4631.
12. Polite BN, Sing A, Sargent DJ, et al. Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE). Cancer. 2012;118: 1083-1090.
13. [Anonymous]. Outreach cuts disparities in colorectal cancer deaths. Cancer Discov. 2013;3:OF4.
14. Sinclair AH, Schymura MJ, Boscoe FP, et al. Measuring colorectal cancer care quality for the publicly insured in New York State. Cancer Med. 2012;1: 363-371.
15. Gross CP, McAvay GJ, Guo Z, Tinetti ME. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007;109: 2410-2419.
16. Tevis SE, Kohlnhofer BM, Stringfield S, et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum. 2013;56: 1339-1348.